🎬 MS Australia is partnering with 'Take My Hand', a powerful Australian feature film with #multiplesclerosis as a central part of the storyline, produced by Bronte Pictures. The film will be shown in cinemas nationally in late 2024. #TakeMyHandTheMovie msaustralia.org.au/takemyhandthem…

#MediaRelease: A new report has revealed the prolonged time to diagnose #multiplesclerosis (MS) and highlighted the urgent need for increased investment in #MS research and enhanced awareness of the disease. #WorldMSDay #MyMSDiagnosis msaustralia.org.au/news/new-repor…

Amazing opportunity within the CRE, led by absolutely amazing experts in the space.

Writing a scientific article: A Step-by-Step Guide for Beginners (1/7)

Have you developed or used living guidance? We are conducting a qualitative study to understand the translation and uptake of living guidance into health policy. Join our study shorturl.at/JVvaD GIN Member World Health Organization (WHO) Cochrane Australia Australian Living Evidence Collaboration

Funded through the 2024 Investigator Grant round, Dr David Skerrett-Byrne from University of Newcastle will soon commence his project on balancing the burden and responsibility of fertility on both women and men and addressing research gaps of male infertility #Men’sHealthWeek2024

The AMSLS is a study collecting data used to improve health outcomes for people with #MS. Participating involves completing surveys in the comfort of your own home. Contribute to making real-life change now, in the lives of people with MS. Learn more👉 bit.ly/3tsNKwO

Great event by Women's Health Research Translation&Impact Network at SAHMRI sharing the podium with Zohra Lassi PhD - زہرہ, Nadia Corsini and Dr Belinda Lunnay talking about impact and engagement, highlighting IMAGENDO and #heraqol #pcos Robinson Research Institute

Hear about four amazing projects by RRI researchers that are destined to change the lives of many mothers and children in the future. Free event, register below ⬇️

🔬 TrialSmart: Education Series on Clinical Trials 🧠 TrialSmart is a series of nine modules for people living with #MS & their communities to raise awareness of and provide education about clinical trials in Australia. #multiplesclerosis #MSresearch bit.ly/3wS7XQP

Our new paper - a Delphi consensus study for identifying stakeholder recommendations for identifying risk predictors for gestational diabetes mellitus and hypertensive disorders of pregnancy mdpi.com/2227-9032/12/1…

Nearly 1 million Australians suffer from endometriosis. Healthcare expenses cost billions. Pathways to diagnosis and treatment remain challenging. Research Tuesdays, Aug13, 5.30pm Prof (mary) Louise Hull Dr Jodie Avery Rebecca o'hara IMAGENDO events.humanitix.com/research-tuesd…

Come along and hear about all things IMAGENDO!

It is with a heavy heart, enormous pride in our achievements to date, and extreme optimism about the future of MS Australia and the #MS community we serve, that I have announced my intention to end my term as Chair of MS Australia in November this year. msaustralia.org.au/news/ms-austra…

The AMSLS is a study collecting data used to improve health outcomes for people with #MS. Participating involves completing surveys in the comfort of your own home. Contribute to making real-life change now, in the lives of people with MS. Learn more 👇 bit.ly/3tsNKwO

Did you see the news? Our very own Dr Jodie Avery and Ali Deslandes 💎 are “the women changing how endometriosis is diagnosed” Bravo ladies 👏 Read it here 👉 adelaidenow.com.au/south-australi…

Ready to kick off a big day in the RRI calendar. Once a year, the RRI community including researchers, staff and partners get together for the annual Symposium to share latest research and projects, and foster collaboration across our Institute.

🚨🚨🚨New publication alert!!!! Our study on hormonal contraception overlap in those who are treated with potentially teratogenic #DMTs is finally published!!! #MS #Research Read the article here 👉doi.org/10.1016/j.msar…

"#Sex and #age differences in #DMT utilization were observed based on teratogenic potential. Hormonal [long-acting reversible #contraceptive] overlap appears higher in those receiving potentially teratogenic DMTs, but overall rates remain low."

Congratulations to our HDA Travel Grant Recipients, rd 2, 2025! Georgia Gosse Alison Roennfeldt Melanie Bertossa Bereket Duko, PhD Millicent Bennett Minnu Jayapal Anna Fragkoudi Reza Amanollahi Evangeline Lovell UniSA Robinson Research Institute Uni of Adelaide TorrensUni 👉health.adelaide.edu.au/healthy-develo…